The Elimination Rate after Clozapine Overdose in Chinese Schizophrenia Patients: A Population Pharmacokinetics Model Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
The Elimination Rate after Clozapine Overdose in Chinese Schizophrenia Patients: A Population Pharmacokinetics Model Study ; volume:48 ; number:04/05 ; year:2015 ; pages:e2-e2
Pharmacopsychiatry ; 48, Heft 04/05 (2015), e2-e2
- Beteiligte Personen und Organisationen
-
Li, A.-N.
Dong, F.
He, J.-L.
Shang, D.-W.
Guo, W.
Li, W.-B.
Lu, W.
Wang, C.-Y.
- DOI
-
10.1055/s-0035-1555803
- URN
-
urn:nbn:de:101:1-2018112106433639224819
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, A.-N.
- Dong, F.
- He, J.-L.
- Shang, D.-W.
- Guo, W.
- Li, W.-B.
- Lu, W.
- Wang, C.-Y.
Ähnliche Objekte (12)
An international research agenda for clozapine-resistant schizophrenia
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Pharmacokinetics of anticoagulant edoxaban in overdose in a Japanese patient transported to hospital
Clozapine-induced agranulocytosis
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
An international research agenda for clozapine-resistant schizophrenia
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Pharmacokinetics of anticoagulant edoxaban in overdose in a Japanese patient transported to hospital
Clozapine-induced agranulocytosis
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
An international research agenda for clozapine-resistant schizophrenia
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Pharmacokinetics of anticoagulant edoxaban in overdose in a Japanese patient transported to hospital
Clozapine-induced agranulocytosis